Indivior Pharmaceuticals Inc
INDV
Classement en actions
#3858
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Prix de l'action
$34.56
Capitalisation boursière
$4.31B
Changement (1 jour)
2.03%
Changement (1 an)
42.27%
Pays
US
Échange Indivior Pharmaceuticals Inc (INDV)
Catégorie
Healthcare
Ratio P/B pour Indivior Pharmaceuticals Inc (INDV)
Ratio P/B au October 2026 TTM : -20.59
Selon les derniers rapports financiers et le cours de l'action de Indivior Pharmaceuticals Inc, le ratio cours/valeur comptable actuel (TTM) est -20.59. À la fin de 2023, le ratio P/B était de 31.28.
Historique du ratio P/B pour Indivior Pharmaceuticals Inc de 2016 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
